Neoprospecta Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 50

Employees

  • Latest Deal Type
  • M&A
  • (Announced)

  • Investors
  • 2

Neoprospecta General Information

Description

Developer of a biotechnology platform designed to help researchers deal with microbiological analysis, management, and control. The company's platform offers biocomputational analysis and quantitative PCR techniques which have created a line of rapid tests for the detection of microorganisms and antibiotic-resistance genes, enabling medical researchers to identify microorganisms using DNA sequencing technologies.

Contact Information

Website
www.neoprospecta.com
Ownership Status
Acquired/Merged
Financing Status
Pending Transaction (M&A)
Corporate Office
  • Avenida Luiz Boiteux Piazza
  • 1302 - Canasvieiras Sapiens Parque
  • Florianopolis, 88054
  • Brazil
+55 (48)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Big Data, Life Sciences
Corporate Office
  • Avenida Luiz Boiteux Piazza
  • 1302 - Canasvieiras Sapiens Parque
  • Florianopolis, 88054
  • Brazil
+55 (48)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neoprospecta Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 13-Nov-2024 Announced Generating Revenue
4. Secondary Transaction - Private 01-Feb-2024 Completed Generating Revenue
3. Later Stage VC 01-Jun-2016 Completed Generating Revenue
2. Early Stage VC 08-Aug-2014 $1.78M $2.03M Completed Generating Revenue
1. Early Stage VC 15-Feb-2013 $249K $249K Completed Generating Revenue
To view Neoprospecta’s complete valuation and funding history, request access »

Neoprospecta Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Neoprospecta Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20160273031-A1 Method, kit and premix for quantitative and discriminative determination of nucleic acids, qdpcr; in vitro method for the quantitative and discriminative diagnosis of biological entities Inactive 18-Nov-2013

Neoprospecta Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neoprospecta Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
IDEE (Other Commercial Products) Venture Capital Minority
Spectra Investments Asset Manager Minority
To view Neoprospecta’s complete investors history, request access »

Ready to get started?

Request a free trial

Neoprospecta FAQs

  • When was Neoprospecta founded?

    Neoprospecta was founded in 2011.

  • Where is Neoprospecta headquartered?

    Neoprospecta is headquartered in Florianopolis, Brazil.

  • What is the size of Neoprospecta?

    Neoprospecta has 50 total employees.

  • What industry is Neoprospecta in?

    Neoprospecta’s primary industry is Biotechnology.

  • Is Neoprospecta a private or public company?

    Neoprospecta is a Private company.

  • What is Neoprospecta’s current revenue?

    The current revenue for Neoprospecta is .

  • How much funding has Neoprospecta raised over time?

    Neoprospecta has raised $2.03M.

  • Who are Neoprospecta’s investors?

    IDEE (Other Commercial Products) and Spectra Investments have invested in Neoprospecta.

  • When was Neoprospecta acquired?

    Neoprospecta was acquired on 13-Nov-2024.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »